Neue Suche | Kongressdetail
mail
Druckansicht
 
 

HER2-Targeted Therapies Summit 2022

Evvnt Promotion / evvnt
-
14.06.2022 - 16.06.2022  Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, USA
Time: 09:00 - 17:00
 
Kongressthemen
The momentum in anti-HER2 drug development is exploding:

Outcomes for HER2-expressing breast cancer are patients constantly improving; diagnostics, trial design and innovative drug design are at an all-time high; complementing the newly accessible HER2 'low' space and wider range of tumor indications; the last year has given us more progress in HER2-targeted therapies than ever before.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Speakers: Cecile Geuijen Chief Scientific Officer and Vice President - Oncology, Merus, Shane Olwill Chief Development Officer, Senior Vice President and Head of Translational Science, Pieris Pharmaceuticals and more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/1003520-2?pid=4832
Frau Ellie Saunders
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
Industry Pricing - Conference + Workshop Day - Standard Rate: USD 4097.0, Industry Pricing - Conference Only - Standard Rate: USD 2899.0
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Ärztekammer für WienAnästhesie in Entwicklungsländern e. V.Swiss Tropical and Public Health InstituteCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioAGEM - Arbeitsgemeinschaft Ethnologie und MedizinHelix - Forschung & Beratung WienHilfswerk AustriaEuropean Health Forum Gastein